Latest Dual Listing News

Zip Co Limited (ASX: ZIP) reported a 46% rise in net profit to $116.4 million for FY26, driven by strong US and ANZ market growth and record cash earnings of $268.9 million. The company also announced an orderly wind down of its New Zealand operations to focus on its core markets.

Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.

Osmond Resources has reinforced the continuity of high-grade critical minerals at its Orión project in Spain, with drill hole SOR-07A delivering promising assay results. The company is on track to release its maiden Mineral Resource Estimate and Scoping Study by Q3 2026, supported by robust mineral processing testwork and a new Frankfurt listing.

Bravura Solutions posted a 49% rise in net profit after tax for FY26 despite a near 10% decline in revenue, supported by strong margin improvements and underlying profit growth. The company declared a 15 cent final dividend, secured a $100 million debt facility, and announced a $50 million share buyback.

Meteoric Resources has secured a secondary listing on the U.S. OTCQB Venture Market, enabling its shares to trade under METOF and enhancing access for U.S. and Brazilian investors without disrupting its ASX presence.

Li-FT Power Ltd. has secured a C$20 million bought deal public offering priced at C$2.90 per share, aimed at funding care and maintenance for the Renard option period and general working capital. The deal includes a 15% over-allotment option and anticipates participation from cornerstone investor Avenir Minerals.

Sparc Technologies has secured commercial traction for its graphene additive ecosparc® with major coatings players AkzoNobel and Petro Vietnam Paint, launched a new additive range for electrostatic coatings, and marked six months of continuous operation at its green hydrogen pilot plant.

Chilwa Minerals has more than doubled its Mpyupyu heavy mineral sands resource to 109.6 million tonnes, defined a maiden niobium-rare earths exploration target at Nakombe, and progressed its planned Nasdaq dual listing with the SEC.

Telix Pharmaceuticals reported a 21% year-on-year revenue jump to US$247 million in Q2 2026, buoyed by strong Precision Medicine sales and a new Regeneron partnership. The company also secured FDA alignment on a pivotal prostate cancer trial and expanded its manufacturing footprint.

Aldoro Resources has secured A$4.3 million through unsecured convertible notes, providing funding to accelerate development at its Kameelburg Critical Minerals Project and exploring a potential Hong Kong Stock Exchange listing.

Almonty Industries will delist from the Toronto Stock Exchange by July 31, 2026, focusing its trading exclusively on Nasdaq to streamline costs and align with where most activity occurs.

James Hardie Industries releases its 2026 AGM materials, highlighting a $4.8 billion sales year boosted by AZEK acquisition, board renewals, and a revamped executive pay structure.